SANGAMO THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Common Stock, Capital Shares Reserved for Future Issuance of 1.20 million shares as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Equity
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-03-30
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 1.20M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.11M shares.
- 2023-12-31: Common Stock, Capital Shares Reserved for Future Issuance 2.86M shares.
- 2022-12-31: Common Stock, Capital Shares Reserved for Future Issuance 4.21M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2025-12-31 | 1.20M shares 10-K · filed 2026-03-30 |
| 2024-12-31 | 2.11M shares 10-K · filed 2025-03-17 |
| 2023-12-31 | 2.86M shares 10-K · filed 2024-03-13 |
| 2022-12-31 | 4.21M shares 10-K · filed 2023-02-23 |
| 2021-12-31 | 4.78M shares 10-K · filed 2022-02-24 |
| 2020-12-31 | 2.48M shares 10-K · filed 2021-02-24 |
| 2019-12-31 | 2.76M shares 10-K · filed 2020-02-28 |